Access cutting-edge diarrhea treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access diarrhea specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diarrhea treatment provided free
The study is designed to evaluate the safety, immunogenicity, and efficacy of the intramuscular administration of a CS6 based vaccine (CssBA) against ETEC co-administered with double mutant labile toxin (dmLT) in preventing moderate-severe diarrhea (MSD) following challenge with ETEC strain B7A in healthy adults. Approximately 72 adult participants, divided into 4 cohorts of 18, will be randomized 1:1 to receive vaccine (45 micrograms CssBA with 0.5 micrograms dmLT) or placebo (normal saline) on
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this diarrhea clinical trial in Baltimore, MD
If you're searching for diarrhea treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diarrhea specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.